Braster S.A.

Equities

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 09:25:54 05/06/2024 pm IST			5-day change	1st Jan Change
0.58 ^PLN	0.00%		0.00%	0.00%

29/05	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Tadeusz Wesolowski acquired additional 4.3% stake in Braster Spólka Akcyjna.

February 17, 2015

Tadeusz Wesolowski acquired additional 4.3% stake in Braster Spólka Akcyjna (WSE:BRA) on February 9, 2015.

Tadeusz Wesolowski completed the acquisition of additional 4.3% stake in Braster Spólka Akcyjna (WSE:BRA) on February 9, 2015.

Latest news about Braster S.A.

Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	04/23/04	CI
Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	03/23/03	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	03/23/03	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	27/22/27	CI
Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	03/22/03	CI
Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	30/21/30	CI
Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	01/21/01	CI
An unknown buyer acquired 21.38% stake in Braster S.A. from Carom Sp. z o.o.	23/21/23	CI
Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	01/21/01	CI
Braster Seeks To Raise Capital	06/18/06	CI
Braster S.A. announced that it has received PLN 0.3 million in funding	11/17/11	CI
Braster S.A. announced that it expects to receive PLN 0.3 million in funding	20/17/20	CI
Braster Negotiates Acquisitions	08/17/08	CI
Braster S.A. announced that it has received funding from Towarzystwo Funduszy Inwestycyjnych PZU SA	07/16/07	CI
Dom Maklerski Banku Ochrony Srodowiska S.A. sold 5.76% stake in Braster S.A..	01/16/01	CI
Medi-Koncept Sp. z o.o. sold 3.15% stake in Braster Spólka Akcyjna.	17/15/17	CI
Tadeusz Wesolowski acquired additional 4.3% stake in Braster Spólka Akcyjna.	17/15/17	CI

Chart Braster S.A.

Duration

Period

More charts

Company Profile

Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
BRASTER S.A.	0.00%	4.31M
GUARDANT HEALTH, INC.	+18.00%	3.43B
IOVANCE BIOTHERAPEUTICS, INC.	+1.41%	2.27B
BGI GENOMICS CO., LTD.	-19.52%	2.03B
VERACYTE, INC.	-19.92%	1.63B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+31.98%	1.16B
CAREDX, INC	+17.25%	714M
SEEGENE, INC.	-9.39%	703M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-22.35%	500M
CURIOX BIOSYSTEMS CO., LTD	-1.29%	279M

Bio Diagnostics & Testing